(Q54561813)
Statements
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome. (English)
Peter Dreger
Michael Rieger
Bärbel Seyfarth
Manfred Hensel
Michael Kneba
Anthony D Ho
Norbert Schmitz
Christiane Pott
1 January 2007
92
1
42-49